Other data showed that APOE4 homozygous patients had an independent association with increased risk for severe COVID-19 infection, even when adjusted for preexisting comorbidities, such as dementia, diabetes, and cardiovascular disease (OR> 2.31, 95% CI: 1.65 to 3.24). Here, APOE is linked to cardiovascular disorder.